| Marcus M. Reidenberg | |
| |
|
|
|
|
|
Introduction: Whither Drug Development? |
|
|
|
| |
| |
|
|
|
|
|
Part I: Changing Perspectives in Drug Development |
|
|
|
| |
|
|
|
|
|
1. The Evolving Drug Discovery and Development Process |
|
|
|
John C. Somberg | |
|
|
|
|
|
2. Redefining Competition in the Pharmaceutical Industry: A Time for Choice |
|
|
|
John Thompson and Jan Gugliotti | |
|
|
|
|
|
Part II: Process Challenges in Drug Development |
|
|
|
| |
|
|
|
|
|
3. The Impact of Liability and Cost Containment on the Drug Development Process |
|
|
|
Martha M. Rumore | |
|
|
|
|
|
4. Managing the Overall Portfolio for Successful Discovery and Development |
|
|
|
Rebecca J. Anderson | |